News Focus
News Focus
icon url

FeMike

03/31/21 5:58 PM

#366020 RE: iwasadiver #366013

True, I was not considering that approval could be gained in some regulatory authorities while further data would be needed in others (fda).
icon url

Survivor2012

03/31/21 6:16 PM

#366032 RE: iwasadiver #366013

Hopefully, this statement is just "boilerplate" risk statement:

"Multiple late stage clinical trials of DCVax-L for GBM, our lead product, may be required before we can obtain regulatory approval."